1,2-dilinoleyloxy-3-(dimethylamino)acetoxypropane | 1169768-12-0

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: 1,2-dilinoleyloxy-3-(dimethylamino)acetoxypropane
• 英文别名: 2,3-bis[(9Z,12Z)-octadeca-9,12-dienoxy]propyl 2-(dimethylamino)acetate
• CAS: 1169768-12-0
• 化学式: C₄₃H₇₉NO₄
• 分子量: 674.105
• InChiKey: QRUOTBNIEWEYDA-KWXKLSQISA-N

计算性质

• 辛醇/水分配系数(LogP)：
  14.4
• 重原子数：
  48
• 可旋转键数：
  38
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.79
• 拓扑面积：
  48
• 氢给体数：
  0
• 氢受体数：
  5

反应信息

• 作为产物：
  描述：

  亚油醇甲基磺酸酯 在 四(三苯基膦)钯 、 sodium hydride 、 三乙胺 、 三氟乙酸 作用下， 以 乙醇 、 二氯甲烷 、 苯 为溶剂， 反应 25.75h， 生成 1,2-dilinoleyloxy-3-(dimethylamino)acetoxypropane
  参考文献：
  名称：

  IMPROVED COMPOSITIONS AND METHODS FOR THE DELIVERY OF NUCLEIC ACIDS

  摘要：

  公开号：

  EP2224912B1

文献信息

• COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF MUTANT EGFR GENE
  申请人：Sah Dinah

  公开号：US20120022132A1

  公开（公告）日：2012-01-26

  The invention relates to a double-stranded ribonucleic acid (dsRNA) targeting a mutant Epidermal Growth Factor Receptor (EGFR), and methods of using the dsRNA to inhibit expression of mutant EGFR.

  这项发明涉及一种针对突变表皮生长因子受体（EGFR）的双链核糖核酸（dsRNA），以及使用该dsRNA抑制突变EGFR表达的方法。
• [EN] AMINO LIPID BASED IMPROVED LIPID FORMULATION<br/>[FR] FORMULATION LIPIDIQUE AMÉLIORÉE À BASE D'AMINO LIPIDE
  申请人：ALNYLAM PHARMACEUTICALS INC

  公开号：WO2009132131A1

  公开（公告）日：2009-10-29

  The present invention provides compositions and methods for the delivery of therapeutic agents to cells. In particular, these include novel lipids and nucleic acid-lipid particles that provide efficient encapsulation of nucleic acids and efficient delivery of the encapsulated nucleic aicd to cells in vivo. The compositions of the present invention are highly potent, thereby allowing effective knock-down of specific target protein at relatively low doses. In addition, the compositions and methods of the present invention are less toxic and provide a greater therapeutic index compared to compositions and methods previously known in the art. Formulae (I), (II), (III), (IV).

  本发明提供了将治疗剂传递给细胞的组合物和方法。特别是，这些包括新型脂质和核酸-脂质颗粒，它们能够高效地封装核酸并将封装的核酸有效地传递到体内细胞中。本发明的组合物非常强效，因此可以在相对较低的剂量下有效地降低特定靶蛋白的表达。此外，与先前已知的技术中的组合物和方法相比，本发明的组合物和方法毒性更低，疗效指数更高。公式（I）、（II）、（III）、（IV）。
• COMPOSITIONS AND METHODS FOR THE DELIVERY OF NUCLEIC ACIDS
  申请人：Hope Michael J.

  公开号：US20110117125A1

  公开（公告）日：2011-05-19

  The present invention provides compositions and methods for the delivery of therapeutic agents to cells. In particular, these include novel lipids and nucleic acid-lipid particles that provide efficient encapsulation of nucleic acids and efficient delivery of the encapsulated nucleic acid to cells in vivo. The compositions of the present invention are highly potent, thereby allowing effective knock-down of specific target protein at relatively low doses. In addition, the compositions and methods of the present invention are less toxic and provide a greater therapeutic index compared to compositions and methods previously known in the art.

  本发明提供了递送治疗剂到细胞的组合物和方法。特别地，这些包括新型脂质和核酸-脂质颗粒，它们提供了核酸的高效封装和封装的核酸在体内细胞中的高效递送。本发明的组合物非常有效，因此可以在相对较低的剂量下有效地降低特定靶蛋白的表达。此外，本发明的组合物和方法比先前在艺术领域中已知的组合物和方法毒性更小，提供更大的治疗指数。
• AMINO LIPIDS AND METHODS FOR THE DELIVERY OF NUCLEIC ACIDS
  申请人：TEKMIRA PHARMACEUTICALS CORPORATION

  公开号：US20160095924A1

  公开（公告）日：2016-04-07

  The present invention provides superior compositions and methods for the delivery of therapeutic agents to cells. In particular, these include novel lipids and nucleic acid-lipid particles that provide efficient encapsulation of nucleic acids and efficient delivery of the encapsulated nucleic acid to cells in vivo. The compositions of the present invention are highly potent, thereby allowing effective knock-down of specific target proteins at relatively low doses. In addition, the compositions and methods of the present invention are less toxic and provide a greater therapeutic index compared to compositions and methods previously known in the art.

  本发明提供了卓越的组合物和方法，用于将治疗剂传递到细胞中。特别是，这些包括新型脂质和核酸-脂质颗粒，可有效地封装核酸并将封装的核酸高效地传递到体内的细胞中。本发明的组合物非常有效，因此可以在相对较低的剂量下有效地抑制特定靶蛋白。此外，与以前已知的组合物和方法相比，本发明的组合物和方法毒性更小，提供更大的治疗指数。
• Improved amino lipids and methods for the delivery of nucleic acids
  申请人：Tekmira Pharmaceuticals Corporation

  公开号：EP2743265A1

  公开（公告）日：2014-06-18

  The present invention provides superior compositions and methods for the delivery of therapeutic agents to cells. In particular, these include novel lipid having the structure below and nucleic acid-lipid particles that provide efficient encapsulation of nucleic acids and efficient delivery of the encapsulated nucleic acid to cells in vivo. The compositions of the present invention are highly potent, thereby allowing effective knock-down of specific target proteins at relatively low doses. In addition, the compositions and methods of the present invention are less toxic and provide a greater therapeutic index compared to compositions and methods previously known in the art.

  本发明提供了向细胞输送治疗剂的优良组合物和方法。其中特别包括具有以下结构的新型脂质和核酸-脂质颗粒，它们能有效地封装核酸并在体内将封装的核酸高效地输送到细胞中。本发明的组合物具有很高的效力，因此能以相对较低的剂量有效地敲除特定的靶蛋白。此外，与本领域以前已知的组合物和方法相比，本发明的组合物和方法毒性更低，治疗指数更高。